» Articles » PMID: 35634501

Case Report: A Chinese Family of Type A Insulin Resistance Syndrome With Diabetes Mellitus, With a Novel Heterozygous Missense Mutation of the Insulin Receptor Gene

Overview
Specialty Endocrinology
Date 2022 May 31
PMID 35634501
Authors
Affiliations
Soon will be listed here.
Abstract

Type A Insulin resistance syndrome (TAIRS) is an autosomal dominant or recessive genetic disorder caused by insulin dysfunction resulting from insulin receptor (INSR) gene mutation. The main features of TAIRS include hyperinsulinemia, abnormal glucose metabolism, and changes in acanthosis nigricans. We identified, in China, a TAIRS family with a novel heterozygous missense gene mutation type. One patient from the Chinese Han family exhibited signs and symptoms of TAIRS and was presented for evaluation. Whole-exome sequencing revealed a heterozygous mutation. Both the patient proband and his father were identified with insulin receptor exon 19c.3472C>T(p.Arg1158Trp), which resulted in a missense mutation that led to replace by a base in the amino acid codon. We found that the patient proband and his father exhibited high insulin and C-peptide release after glucose stimulation by insulin and C-peptide release tests. At the same time, we also ruled out the possibility of islet βcell tumor through relevant examinations. These findings indicate that the INSR gene mutation may cause pancreatic β cell functional impairment and contribute to the development of diabetes.

Citing Articles

Changes in Cells Associated with Insulin Resistance.

Szablewski L Int J Mol Sci. 2024; 25(4).

PMID: 38397072 PMC: 10889819. DOI: 10.3390/ijms25042397.


Insulin Resistance: The Increased Risk of Cancers.

Szablewski L Curr Oncol. 2024; 31(2):998-1027.

PMID: 38392069 PMC: 10888119. DOI: 10.3390/curroncol31020075.


Alterations in , , , and Genes in a Case of Late-Onset Massive Tumoral Calcinosis.

Leow M, Ang J, Bi X, Koh E, McFarlane C AACE Clin Case Rep. 2023; 9(5):153-157.

PMID: 37736313 PMC: 10509374. DOI: 10.1016/j.aace.2023.05.004.


An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus.

Mahgoub M, Ali I, Adeghate J, Tekes K, Kalasz H, Adeghate E Int J Mol Sci. 2023; 24(11).

PMID: 37298274 PMC: 10253663. DOI: 10.3390/ijms24119328.


Acanthosis Nigricans: Pointer of Endocrine Entities.

Radu A, Carsote M, Dumitrascu M, Sandru F Diagnostics (Basel). 2022; 12(10).

PMID: 36292208 PMC: 9600076. DOI: 10.3390/diagnostics12102519.

References
1.
Maassen J, Tobias E, Kayserilli H, Tukel T, Yuksel-Apak M, dHaens E . Identification and functional assessment of novel and known insulin receptor mutations in five patients with syndromes of severe insulin resistance. J Clin Endocrinol Metab. 2003; 88(9):4251-7. DOI: 10.1210/jc.2003-030034. View

2.
Cheatham B, Kahn C . Insulin action and the insulin signaling network. Endocr Rev. 1995; 16(2):117-42. DOI: 10.1210/edrv-16-2-117. View

3.
Moller D, Yokota A, White M, PAZIANOS A, Flier J . A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem. 1990; 265(25):14979-85. View

4.
Davis A, Yarasheski K, White N, Canter C, Marshall B . Defective insulin receptors in Rabson-Mendenhall syndrome cause complete peripheral insulin resistance but minimal hepatic insulin response remains. Pediatr Diabetes. 2004; 1(2):66-73. DOI: 10.1034/j.1399-5448.2000.010203.x. View

5.
Young J, Morbois-Trabut L, Couzinet B, Lascols O, Dion E, Bereziat V . Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes. 2005; 54(6):1873-8. DOI: 10.2337/diabetes.54.6.1873. View